Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Randomized, Double-Blind, Parallel Comparative, Phase II Study to Evaluate the Efficacy and Safety of Intravenous Infusion With Nemonoxacin Versus Moxifloxacin in Treating Adult Patients With Community-Acquired Pneumonia

NCT01944774 is registered in ClinicalTrials.gov with TaiGen Biotechnology Co., Ltd. as lead sponsor.

NCT NCT01944774
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01944774 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Randomized, Double-Blind, Parallel Comparative, Phase II Study to Evaluate the Efficacy and Safety of Intravenous Infusion With Nemonoxacin Versus Moxifloxacin in Treating Adult Patients With Community-Acquired Pneumonia
Lead sponsor
TaiGen Biotechnology Co., Ltd.
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2013
Completion date
December 31, 2013
Enrollment
207 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pneumonia